JMJD5 forms a complex with CRY1–FBXL3 and leads to CRY1 degradation. by Anand R. Saran (6034127)

“…(D) Knockdown of FBXL3 decreases JMJD5 co-IP with CRY1. Densitometric analysis showing ratio of JMJD5 to CRY1 signals from these experiments (mean ± SEM, <i>n</i> = 4) are shown in (E). …”

Table_1_Ultrasound for Non-invasive Assessment and Monitoring of Quadriceps Muscle Thickness in Critically Ill Patients With Acute Kidney Injury.DOCX by Alice Sabatino (5150417)

Type I IFN pretreatment inhibits nLuc expression in vertebrate cells in time- and concentration-dependent mode. by Josephine M. Reynaud (732822)

Colocalization of CD4⁺ and CD8⁺ lymphocytes with F4/80⁺ macrophages increases as infection with <i>Salmonella</i> persists. by Kristin L. Rosche (754117)

Brain acylcarnitines. by Dawn B. Lammert (21175128)

One-way sensitivity analysis, <i>Immediate ART</i> strategy compared to <i>ART<350/μL</i>. by Eric N. Ouattara (6890174)

Schematic representation of the workflow. by Mohamed E. Elnageeb (21819928)

“…Results showed that the L12F variant increased structural compactness, as indicated by diminished solvent accessibility, a reduced radius of gyration, and a decrease in hydrogen bonding capacity. The A56V variant destabilized the ALOX5AP, demonstrating elevated root mean square deviation (RMSD), augmented solvent-accessible surface area, and diminished ALOX5AP compactness. …”

FASN was not altered in fasting in mice with reduced myocardial PPARα. by Natasha Fillmore (322163)

Viability of <i>L</i>. <i>intracellularis</i>. by Huan W. Yang (19746645)

Scaffold production. by Fabian Westhauser (5314436)

Total Circulating Progenitor Cell (CPC) analysis through pregnancy and postpartum in control, type 1 and type 2 diabetic women. by Patricia D. A. Lima (707898)

Table 1_Eculizumab is efficacious and safe in pediatric patients with various forms of hemolytic uremic syndrome: a retrospective clinical experience of a tertiary center.docx by Naama Lax (20998004)

“…</p>Results<p>Twenty-four pediatric patients (median age 5.8 years) were included: 13 with aHUS, 5 with STEC-HUS, and 6 with TA-TMA. A complete TMA response was achieved in 12 (50%) of the patients overall: 7 (54%) with aHUS, 3 (60%) with STEC-HUS, and 2 (33%) with TA-TMA. …”

Effect of weighted sled towing on sprinting effectiveness, power and force-velocity relationship by Patrícia Dias Pantoja (5824004)

“…<div><p>This study aimed to compare the components of force-velocity (F-V) and power-velocity (P-V) profiles and the mechanical effectiveness of force application (or force ratio–RF) among various sled-towing loads during the entire acceleration phase of a weighted sled sprint. Eighteen sprinters performed four 50-m sprints in various conditions: unloaded; with a load corresponding to 20% of the athlete’s body mass (BM); with a load of 30% BM; and with a load of 40% BM. …”

S1 Data - by Razia Liaqat (17873634)

“…At the end of growth experiment, fish in all four groups were exposed to <i>Staphylococcus aureus</i> (5×10⁵ CFU/ml). After <i>S</i>. <i>aureus</i> challenge, fish fed with <i>B</i>. …”

AR negative triple negative or “quadruple negative” breast cancers in African American women have an enriched basal and immune signature by Melissa Davis (3522224)

“…AR-negative patients have a (66.60; 95% CI, 32–146) odds ratio of being basal-like compared to other PAM50 subtypes, and this is associated with an increased time to progression and decreased overall survival. …”

Analysis of amino acid levels. by Dawn B. Lammert (21175128)

Reduction in myocardial PPARα prevents cardiac triglyceride accumulation. by Natasha Fillmore (322163)

Reduced cell viability in Dkp23- and Vaccine-infected PK-15 cells. by Huan W. Yang (19746645)

Control or fasted mice with reduced myocardial PPARα do not have elevated levels of protein oxidation. by Natasha Fillmore (322163)

Regulation of NF-κB target genes. by Huan W. Yang (19746645)